New drugs in the treatment of chronic hepatitis C
Objectives: To analyze the efficacy and safety of the new direct antiviralagents (DAA) that will become the new therapeutic arsenal for thetreatment of hepatitis C. Methods:We carried out a research in the electronic database with thefollowing criteria: phase II and III clinical trials (CT) publish...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2014-04-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/7314.pdf |